Current Assets
Short-Term Investments
Vertex Pharmaceuticals Short-Term Investments increased by 15.1% to $1.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $1.53B to $1.75B. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows an upward trend with a 17.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests the company is effectively deploying excess cash to earn returns; a decrease may indicate cash usage for operations or acquisitions.
Detailed definition
These are marketable securities and other financial instruments that the company intends to hold for more than three mon...
Peer comparison
Common for companies with significant cash reserves and active treasury management.
Metric ID:
short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $644.32M | $685.19M | $729.90M | $638.00M | $551.20M | $599.20M | $274.50M | $1.12B | $1.09B | $818.00M | $849.20M | $1.01B | $1.22B | $1.29B | $1.55B | $1.53B | $1.41B | $1.35B | $1.52B | $1.75B |
| QoQ Change | — | +6.3% | +6.5% | -12.6% | -13.6% | +8.7% | -54.2% | +309.5% | -3.5% | -24.6% | +3.8% | +19.3% | +19.9% | +5.8% | +20.3% | -1.3% | -7.6% | -4.5% | +13.1% | +15.1% |
| YoY Change | — | — | — | — | -14.5% | -12.5% | -62.4% | +76.2% | +96.9% | +36.5% | +209.4% | -9.9% | +12.0% | +57.1% | +82.1% | +50.6% | +16.1% | +4.8% | -1.5% | +14.9% |
Range$274.50M – $1.75B
CAGR+23.5%
Avg YoY Growth+34.7%
Median YoY Growth+15.5%
Current Streak2 quarters growth
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's short-term investments?
- Vertex Pharmaceuticals (VRTX) reported short-term investments of $1.75B in Q1 2026.
- How has Vertex Pharmaceuticals's short-term investments changed year-over-year?
- Vertex Pharmaceuticals's short-term investments increased by 14.9% year-over-year, from $1.53B to $1.75B.
- What is the long-term trend for Vertex Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's short-term investments has grown at a 17.8% compound annual growth rate (CAGR), from $670.70M to $1.52B.
- What does short-term investments mean?
- Liquid investments maturing between three months and one year.